ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Advancing Precision Oncology: Expanding Patient Access to Biomarkers and Testing Capabilities Part 3"
Episode Synopsis
In this third episode on advancing precision oncology, we continue discussing the role of expanding patient access to biomarkers and evolving testing capabilities. Our precision oncology experts delve into the challenges and opportunities that lie ahead in the rapidly changing landscape. They explore advancements in data, machine learning, and testing capabilities on the horizon. They also discuss the roles of payers and healthcare providers in ensuring patient access to these advancements.
In God we trust